Aurora Spine Corporation : AURORA SPINE APPOINTS NATIONAL SALES MANAGER IN THE UK

Carlsbad, California, September 5, 2014 /Marketwired/ - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Mike Coupland as National Sales Manager in the United Kingdom (UK).  Mr. Coupland will manage Aurora's UK sales efforts. Under Mr. Coupland's leadership, the Aurora UK sales team expects to strengthen its presence in the UK market.

"I am delighted to welcome Mike to the team, he is a great addition. Mike has the perfect balance of start-up and multi-national experience to succeed in his task of building our direct sales presence in the UK market" said Richard Moss, Aurora's Vice President of International Business Development.

Prior to joining Aurora Spine, Mr. Coupland was the National Sales Manager for QSpine, where he was responsible for managing QSpine's sales force across the UK and for growing its business.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed success of the company's sales efforts. Aurora Spine cautions investors of its securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt
President and Chief Executive Officer
(760) 424-2004

Eric Fronk
Chief Financial Officer
(760) 424-2004